My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 13

    1.

    Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.

    Putluri N, Shojaie A, Vasu VT, Vareed SK, Nalluri S, Putluri V, Thangjam GS, Panzitt K, Tallman CT, Butler C, Sana TR, Fischer SM, Sica G, Brat DJ, Shi H, Palapattu GS, Lotan Y, Weizer AZ, Terris MK, Shariat SF, Michailidis G, Sreekumar A.

    Cancer Res. 2011 Dec 15;71(24):7376-86. Epub 2011 Oct 11.

    PMID:
    21990318
    [PubMed - indexed for MEDLINE]

    Related citations

    2.

    Identification of an unintended consequence of Nrf2-directed cytoprotection against a key tobacco carcinogen plus a counteracting chemopreventive intervention.

    Paonessa JD, Ding Y, Randall KL, Munday R, Argoti D, Vouros P, Zhang Y.

    Cancer Res. 2011 Jun 1;71(11):3904-11. Epub 2011 Apr 12.

    PMID:
    21487034
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    3.

    CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.

    Overdevest JB, Thomas S, Kristiansen G, Hansel DE, Smith SC, Theodorescu D.

    Cancer Res. 2011 Jun 1;71(11):3802-11. Epub 2011 Apr 11.

    PMID:
    21482678
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    4.

    Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer.

    Thomas S, Overdevest JB, Nitz MD, Williams PD, Owens CR, Sanchez-Carbayo M, Frierson HF, Schwartz MA, Theodorescu D.

    Cancer Res. 2011 Feb 1;71(3):832-41. Epub 2010 Dec 10.

    PMID:
    21148751
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    5.

    Serum vitamin D and risk of bladder cancer.

    Mondul AM, Weinstein SJ, Männistö S, Snyder K, Horst RL, Virtamo J, Albanes D.

    Cancer Res. 2010 Nov 15;70(22):9218-23. Epub 2010 Oct 26.

    PMID:
    20978193
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    6.

    Phosphorylation of RalB is important for bladder cancer cell growth and metastasis.

    Wang H, Owens C, Chandra N, Conaway MR, Brautigan DL, Theodorescu D.

    Cancer Res. 2010 Nov 1;70(21):8760-9. Epub 2010 Oct 12.

    PMID:
    20940393
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    7.

    MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.

    Choudhury A, Nelson LD, Teo MT, Chilka S, Bhattarai S, Johnston CF, Elliott F, Lowery J, Taylor CF, Churchman M, Bentley J, Knowles MA, Harnden P, Bristow RG, Bishop DT, Kiltie AE.

    Cancer Res. 2010 Sep 15;70(18):7017-26.

    PMID:
    20843819
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    8.

    Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue.

    Wolff EM, Chihara Y, Pan F, Weisenberger DJ, Siegmund KD, Sugano K, Kawashima K, Laird PW, Jones PA, Liang G.

    Cancer Res. 2010 Oct 15;70(20):8169-78. Epub 2010 Sep 14.

    PMID:
    20841482
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    9.

    Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells.

    Harada Y, Kanehira M, Fujisawa Y, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y, Katagiri T.

    Cancer Res. 2010 Jul 15;70(14):5829-39. Epub 2010 Jun 29.

    PMID:
    20587513
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    10.

    Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.

    Lindgren D, Frigyesi A, Gudjonsson S, Sjödahl G, Hallden C, Chebil G, Veerla S, Ryden T, Månsson W, Liedberg F, Höglund M.

    Cancer Res. 2010 May 1;70(9):3463-72. Epub 2010 Apr 20.

    PMID:
    20406976
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    11.

    Attenuation of tumor growth by formation of antiproliferative glycosaminoglycans correlates with low acetylation of histone H3.

    Nilsson U, Johnsson R, Fransson LA, Ellervik U, Mani K.

    Cancer Res. 2010 May 1;70(9):3771-9. Epub 2010 Apr 20.

    PMID:
    20406966
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    12.

    Activation of Hedgehog signaling by the environmental toxicant arsenic may contribute to the etiology of arsenic-induced tumors.

    Fei DL, Li H, Kozul CD, Black KE, Singh S, Gosse JA, DiRenzo J, Martin KA, Wang B, Hamilton JW, Karagas MR, Robbins DJ.

    Cancer Res. 2010 Mar 1;70(5):1981-8. Epub 2010 Feb 23.

    PMID:
    20179202
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    13.

    p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.

    Kumar B, Koul S, Petersen J, Khandrika L, Hwa JS, Meacham RB, Wilson S, Koul HK.

    Cancer Res. 2010 Jan 15;70(2):832-41. Epub 2010 Jan 12.

    PMID:
    20068172
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk